Skip to main content

Outbreak of haemolytic uraemic syndrome in Norway caused by stx 2-positive Escherichia coliO103:H25 traced to cured mutton sausages



On 20–21 February 2006, six cases of diarrhoea-associated haemolytic uraemic syndrome (HUS) were reported by paediatricians to the Norwegian Institute of Public Health. We initiated an investigation to identify the etiologic agent and determine the source of the outbreak in order to implement control measures.


A case was defined as a child with diarrhoea-associated HUS or any person with an infection with the outbreak strain of E. coli O103 (defined by the multi-locus variable number tandem repeats analysis (MLVA) profile) both with illness onset after January 1st 2006 in Norway. After initial hypotheses-generating interviews, we performed a case-control study with the first fifteen cases and three controls for each case matched by age, sex and municipality. Suspected food items were sampled, and any E. coli O103 strains were typed by MLVA.


Between 20 February and 6 April 2006, 17 cases were identified, of which 10 children developed HUS, including one fatal case. After pilot interviews, a matched case-control study was performed indicating an association between a traditional cured sausage (odds ratio 19.4 (95% CI: 2.4–156)) and STEC infection. E. coli O103:H25 identical to the outbreak strain defined by MLVA profile was found in the product and traced back to contaminated mutton.


We report an outbreak caused by a rare STEC variant (O103:H25, stx 2-positive). More than half of the diagnosed patients developed HUS, indicating that the causative organism is particularly virulent. Small ruminants continue to be important reservoirs for human-pathogen STEC. Improved slaughtering hygiene and good manufacturing practices for cured sausage products are needed to minimise the possibility of STEC surviving through the entire sausage production process.

Peer Review reports


Shiga toxin producing E. coli (STEC) can cause bloody diarrhoea which in 2–15% of cases, particularly in children, develop into haemolytic uraemic syndrome (HUS) which can lead to renal failure and death [1]. More than 90% of diarrhoea-associated HUS cases are due to STEC infections. Routine diagnosis and surveillance of STEC-infections was originally developed for serotype O157:H7 of STEC. However, non-O157 E. coli infections are in certain geographic regions considered to be at least equally important, but may in general be underdiagnosed [2].

Sporadic STEC infections may be transmitted through food, contact with animals or farming environments or by person-to-person, the last two affecting mainly young children [3]. Outbreaks are mainly foodborne, and have been associated with a wide variety of products, including undercooked minced beef, unpasteurized milk or apple juice, yoghurt, cheese, lettuce, vegetables, cured sausages and drinking water [1].

In Norway (population 4.6 million), around 10 to 20 cases of sporadic STEC infection are notified annually. Most have only bloody diarrhoea [4], and approximately half have been acquired in Norway. The only documented foodborne STEC outbreak in Norway occurred in 1999 with four confirmed cases of E. coli O157:H7 infection, most likely caused by contaminated domestically produced lettuce [5].

On 20–21 February 2006, a cluster of four diarrhoea-associated HUS cases was reported to the Norwegian Institute of Public Health (NIPH) from an academic hospital in Oslo. Enquiries to other hospitals in Norway identified two additional HUS cases diagnosed since the beginning of 2006. Since hospital episode statistics indicate less than a handful HUS cases in children per year in Norway, we suspected an outbreak and launched an investigation in order to identify the source and stop the outbreak.


Epidemiological investigation

Case definition and case finding

For the outbreak investigation we defined an outbreak-related case as a child less than 16 years old, hospitalised in Norway with diarrhoea-associated HUS or a person of any age with an infection with the outbreak strain of E. coli O103 (defined by a specific multi-locus variable number tandem repeats analysis (MLVA) profile), both with onset after January 1, 2006. We alerted all medical microbiological laboratories and clinicians, in particular paediatric nephrologists, of the outbreak and requested rapid reporting of suspected cases.

Hypotheses-generating interviews

We interviewed all cases (or, if <16 years of age, their parents) in person or by phone with our standard 14-paged structured hypothesis-generating questionnaire covering clinical symptoms, demographics, food and drinks consumed, animal contacts and environmental exposures in the seven days preceding onset of diarrhoea. Most cases were contacted repeatedly to obtain a complete picture of their exposures. Local public health doctors or district food safety authorities interviewed school and kindergarten staff regarding foods eaten by cases in these locations and forwarded the data to the NIPH.

Case-control study

The case-control study started on February 22 and included all cases reported to the NIPH. The study was designed to measure association between disease and consumption of 26 food items that were suspected based on the hypothesis-generating interviews, including several types of meat, dairy products and vegetables, some of which were specified with brand names. Three controls per case were randomly selected from the computerised national population register matched by (closest) date of birth, gender and municipality of residence. For the cases, consumption of food items was asked for the period of one week before the onset of diarrhoea; the matched controls answered for the corresponding period. Controls that had travelled abroad during this period, or that did not speak Norwegian were excluded. Trained personnel interviewed cases and controls by telephone.

On February 24, with data from the first 6 cases and their 18 matched controls, the analysis indicated minced meat of brand A as the source. We reported this to the National Food Safety Authority (NFSA) and then continued the investigation. On March 14, when case number 11 was confirmed, hypothesis-generating interviews led us to suspect another product. We then extended the case-control questionnaire to include this product and interviewed all cases and controls also with the revised questionnaire. The second analysis of the case-control data included fifteen cases known by March 17. Results were reported on March 20 to the NFSA.

Statistical analysis

Interview data were entered in Microsoft Office Excel 2003. Answers were coded 'yes', 'no' or 'unknown'. Unknown was coded as missing in the analysis. The descriptive analysis and the conditional logistic regression models were performed in STATA 9.2 (Stata Corporation, College Station, TX, USA). Bivariate conditional regression analyses were initially run for all exposures using Wald chi-square test for significance. Risk factors with a p-value <0.2 were included in a multivariate conditional logistic regression model. Only factors to which more than half of the cases had been exposed, were considered in the model. We removed from the model one exposure at a time using the Wald p-value <0.1 as the elimination criterion. The results are reported as matched odds ratios (mORs) with 95% confidence intervals and two-tailed Wald p-values for the regression coefficients. Because of the small numbers of subjects in the first case-control study, it was not possible to obtain a conditional maximum-likelihood estimate of the odds ratio for all exposures. For these exposures, we calculated the median unbiased estimate (MUE) of the odds ratio and exact 95% confidence intervals using LogXact 4 (Cytel Software Corporation, Cambridge, MA, USA).

Ethical considerations

The National Committees for Research Ethics in Norway consider outbreak investigations as public health practice, and approval by the research ethical committee is not needed as long as the objective is to control the outbreak (this is in line with the 1991 International Guidelines for Ethical Review of Epidemiological Studies by the Council for International Organisations of Medical Sciences). Ooutbreak investigations follow the regulations on patient privacy and protection as stated in the Norwegian Law on Communicable Disease Control.

Microbiological and environmental investigation


Initial isolation of STEC from stool samples was attempted at the primary diagnostic laboratories. Because several of these laboratories routinely only test for E. coli O157 using sorbitol MacConkey's (SMAC)-agar, they were early on instructed to examine also for E. coli O103 or refer suspect samples or strains to an expert laboratory. All suspected STEC isolates were sent to NIPH for verification, DNA-profiling by MLVA [6] and examination of virulence factors, including the genes eae, stx 1 and stx 2, using an octaplex PCR [7]. This PCR method was also implemented to screen multiple colonies from mixed cultures. Isolates which tested positive for eae, stx or both, were examined further for serotype affiliation and MLVA profile. Since it was observed that the outbreak strain displayed a distinct morphology on Chromocult coliform agar (Chromocult; Merck, UK) [8], this medium was also used to select suspect colonies from mixed cultures.

The Stx2 toxin was subtyped according to the scheme proposed by Persson et al. [9] by full sequencing of the stxAB 2 operon. A few strains were also sent to the WHO Escherichia reference centre at State Serum Institute in Denmark for verification and further characterization.

After an initial Widal agglutination test performed at the NIPH, available sera from cases were sent to the German HUS reference laboratory at the Münster University Clinic to perform IgM/IgG immunoblot assays against serogroup O103 and other important HUS-associated serogroups.

Food-products and production sites

The NFSA collected leftover food items from patients' homes and products from shops of purchase. The NFSA also traced the suspected products and their ingredients, sampled raw materials and ingredients and inspected and sampled the producers' premises. Brand labels and batch numbers of items were checked. Samples were tested for the presence of STEC O103 at the Norwegian School of Veterinary Science using modifications of two methods (methods no. 125 and 164) suggested by the Nordic Committee on Food Analysis [10], including automated immunomagnetic separation specific for E. coli O103 (Dynabeads STEC/VTEC O103; Invitrogen Corp., Oslo, Norway). Presumptive STEC O103 isolates from the immunomagnetic separation procedure which showed the distinct colony morphology on Chromocult coliform agar [8], were sent to the NIPH for confirmation, virulence factor testing and MLVA typing as specified above.


Epidemiologic investigation

Case finding

Between February 20 and April 7, 2006, 17 cases were identified: 10 cases of HUS, six cases of diarrhoea and one asymptomatic case (who was the mother of a HUS case). All 10 HUS cases and four diarrhoea cases were hospitalised. One HUS patient died within five days after hospitalisation. Sixteen cases had diarrhoea of which 14 had bloody diarrhoea. Two cases also reported haematuria.

Dates of symptom onset ranged between January 22 and March 13, 2006, with 15 cases reporting first symptoms between February 12 and March 13 (Figure 1). Ten cases came from mid-Norway, in two neighbouring counties. Among the other cases residing in seven other counties (Figure 2), one had visited one of the first counties the week before illness. Eleven (65%) cases were female, and all cases were children aged 1–11 years, except the asymptomatic case (aged 40) and another adult (aged 18) with diarrhoea only. All HUS cases were less than 9 years old.

Figure 1

Distribution of cases of haemolytic uraemic syndrome (HUS) and E. coli O103 infection by week of onset of symptoms, Norway, January-March 2006 (n = 16).

Figure 2

Distribution of outbreak related cases of HUS and E. coli O103 infection by county, Norway, January-March 2006 (n = 17).

Hypothesis-generating (pilot) interviews

The interviews of the first six HUS cases were completed on February 22 and revealed no recent travel history, or common exposures to restaurants, events or animal contact. However, some food products were commonly mentioned, including minced meat of one specific brand. By March 14, an additional five cases had been notified. Continued hypothesis-generating interviews with these new cases identified another common exposure; a traditional cured sausage product called 'morrpølse'. This product had been mentioned by only one of the first six patients. However, repeated interviews with the patients' parents specifically asking about possible exposure to this sausage product by visiting friends, relatives or at other places, found that this product could be linked to all cases except one.

Case-control study

In the first case-control study, all six HUS cases and six of 18 matched controls had eaten minced beef from producer A (OR = 8.5 p = 0.04). At this stage in the investigation no pathogen was identified in the six HUS cases. The second case control study including all 15 cases known to us at that time and their 45 matched controls identified several meat products to be associated with illness (Table 1). In the final multivariable model, only the consumption of traditional cured sausage ("morrpølse") and eating beefburger at a fast-food restaurant of chain B were independently associated with illness (Table 1).

Table 1 Results of case-control study of causes of E. coli O103 outbreak in Norway, January-March 2006. The matched analysis includes 15 cases and 45 controls.

Microbiological and environmental investigation


Stool or serum specimens were obtained from all 17 cases (Table 2). Nine of the ten HUS cases were confirmed as having an E. coli O103 infection, using either stool sample culture (four cases) or serology (five cases). One HUS case had negative results for serogroup O103 by both methods, but was positive with LPS IgM serology for E. coli O157. Six cases with diarrhoea and one asymptomatic family contact had a positive stool sample for E. coli O103. The serotype of the outbreak strain was identified as E. coli O103:H25. All eleven patient isolates were positive for the eae-gene (intimin encoding), but Shiga toxin genes could be detected in only two isolates, both with Shiga toxin 2 only. By sequencing, the outbreak strain was allocated to subtype Stx2-O157-EDL933 according to the subtyping scheme suggested by Persson et al. [9]. The patients concerned developed HUS. All outbreak isolates, irrespective of their stx-status, belonged to the same MLVA-profile cluster, which were markedly different from the collection of 106 other E. coli O103 isolates at the NIPH except for two strains from HUS patients diagnosed in 2003 and 2005 respectively. A dendrogram comparing the isolates from the present outbreak with epidemiologically unrelated O103 strains has been presented previously by Linstedt et al. [6].

Table 2 Evidence of E.coli O103 infection in HUS cases (10) and diarrhoeal cases (6) and asymptomatic case (1), January-March 2006 (n = 17)

Food-products and production sites

Two days after the product recall, E. coli O103 with the outbreak MLVA-profile was isolated in unopened packages of the recalled cured "morrpølse". This product was produced only in facility A which had distributed 3.5 tonnes nationwide between December 2005 and March 20, 2006. The sausage contains mutton and pork in addition to starter culture, spices and preservatives. The curing process takes approximately three weeks. Low pH, low water activity and an added bacterial culture are the main barriers against pathogen growth. No heat treatment is included in the production process. Among the different ingredients of the incriminated sausage, E. coli with the distinct characteristics of the outbreak strain was only recovered from mutton.

From facility A, the outbreak strain was also traced to production plant B (frozen mutton), then to slaughterhouse C (mutton) and then to four farms (sheep).

Public health action

On February 24, based on our first report, the NFSA issued a public warning against minced beef from producer A and the producer withdrew all minced beef from the production facility they believed to be the origin of the suspected food based on the geographical distribution of the cases. The importance of good kitchen hygiene and proper cooking of minced meat was stressed by health authorities.

On March 20, based on the extended case-control study, the NFSA withdrew the incriminated cured sausages ("morrpølse") from the market and warned the public against eating these products produced between December 1, 2005 and March 20, 2006. The production facility A was closed, and then cleaned and inspected before production could resume. Sheep slaughtering techniques were changed to reduce contamination.


We have reported an outbreak of haemolytic uremic syndrome caused by a highly virulent strain of Shiga toxin 2 producing E. coli O103:H25. Dry cured sausages were identified as the vehicle of infection, as evidenced by results of a case control study and subsequent isolation of the outbreak strain in the product.

We also found a strong association between illness and consumption of beefburger at a fast food restaurant chain. The burgers were produced in the same facility as the initially suspected minced beef. The first case-control study that implicated minced beef from producer A included only six cases. Due to the emergency of the outbreak, these cases were used for both generating and testing the hypotheses, which might have introduced an information bias. Later in the investigation, after the suspicion about minced beef was announced, there were many reports about the "burger-bug" in the media. We believe that recall bias may have caused the association with beefburgers from chain B in the second larger case-control study.

Long after the product had been withdrawn, it was discovered through immunoblot analysis that one case (no 8, table 2) probably was infected by another E. coli than the outbreak strain, and thus was proably not related to the outbreak. We have still presented the analysis including this case (table 1) because it fulfilled the case definition used during ther investigation, and it was this analysis that formed the basis for decision making at the time. This illustrates the dillemma of choosing between a sensitive and a specific case definition during an outbreak investigation.

This investigation illustrates that even when it is considered necessary to warn customers about suspected products early in the investigation, it is important to continue investigating alternative sources vigorously until the source can be confirmed and no more cases occurs after the source is removed.

Genotyping of the isolates was pursued using a recently published MLVA assay, which is designed for differentiation within all E. coli serotypes [6]. MLVA is generally considered to be a robust and fast typing method with high discriminatory power [6, 11]. Prospective MLVA subtyping of STEC may be used to detect clusters of related cases and ascertain the source of infection. The high discriminatory power of the MLVA method for O103 as well as for E. coli in general, has been documented by Lindstedt et al. [6].

The outbreak was detected by clinicians reporting a cluster of HUS cases, and not by an increase in laboratory verified E. coli O103 infections. The same has been the case in a few other reported STEC outbreaks; one STEC O111 outbreak in Australia [12], some German STEC O157 (sorbitol-fermenting) outbreaks [13, 14] and two Italian HUS outbreaks involving non-O157 strains [15, 16]. Most of these outbreaks would have been missed by screening faecal samples using sorbitol MacConkey's (SMAC) agar as this medium is intended for the detection of of sorbitol-negative O157 strains. Underreporting of non-O157 E. coli strains is assumed due to the current laboratory methods used in many countries [2, 16], including Norway. Therefore, surveillance of diarrhoea-associated HUS may be needed for early detection of STEC outbreaks [17].

STEC O103:H2 is one of the most frequently isolated non-O157 serotypes in many European countries and can cause severe illnesses comparable to those caused by serogroup O157 [18]. It was first identified as a causative agent of HUS in 1992 [19], however cases are mainly sporadic and outbreaks of STEC O103:H2 have rarely been reported. One family outbreak was reported in Japan [20] and one day-care centre outbreak in Argentina [21], both caused by stx 1-positive STEC O103. The sources were not identified. The serotype of the present outbreak – O103:H25 – is extremely rare. A few sporadic cases have been reported [22, 23], and where the toxin profile has been reported, all have been stx 1-positive. Outbreaks or sporadic cases caused by stx 2 positive E. coli O103:H25 have to our knowledge never previously been identified.

More than half the patients developed HUS. In spite of widespread testing of contacts and enhanced laboratory procedures during the outbreak, very few additional mild cases were identified. Only one family member of a HUS case reported symptoms. An increase in non-outbreak related STEC infections in patients with milder symptoms were reported, which could indicate that the sensitivity of testing improved during and after the outbreak. Thus, we believe that the outbreak strain was particularly virulent. Also in some other outbreaks, a similar high proportion of HUS cases have been observed [13, 14, 24]. STEC strains, independent of serogroup, that contain the eae gene and produce Stx2 are much more likely to cause severe disease and HUS than are those that produce Stx1 [2527]. In addition, sequencing of the stx 2 operon showed that it encoded a Stx2 variant that is more often associated with HUS than other subtypes [9]. The reason why stx-genes could be demonstrated in only two of the outbreak isolates, despite the fact that the isolates were closely related genetically, will be the subject further research. Bielaszewska et al studied patients with HUS hospitalized in Austria and Germany, and found that at the time of microbiological analysis, 5% of HUS patients shed no longer the causative STEC, but excreted stx-negative derivatives that had lost stx during infection [28]. Other studies have also shown that STEC may loose the stx-genes during infection or subcultivation [2932].

A Danish study found that serogroups O157 and O103 were independent risk factors for bloody diarrhoea [33]. Earlier reports have suggested that E. coli O103:H2, can be regarded as an emerging foodborne pathogen [34] and warned that additional uptake of stx 2-phages by E. coli O103 can result in the emergence of a strain with increased virulence as has occurred with E. coli O26 [18, 34].

The two cases diagnosed with E. coli O103:H25 with the same MLVA- and virulence profile in 2003 and 2005 may indicate that this strain has been present over a longer time period in Norway. However, it is not known if these cases were related to cured sausage or other products containing mutton. Earlier reports have shown that Norwegian sheep may carry human-pathogenic STEC [35], including STEC O103 [36]. Mutton products were recently associated with an outbreak of STEC O26 in France [37].

Fecal contamination of carcasses is practically unavoidable, and STEC are able to survive the fermentation, drying, and storage stages of sausage production [38], as shown in experimental studies [3941]. Several STEC outbreaks caused by dry fermented sausages have been described [12, 4245]. These products are often made of combinations of meat mixed with spices and curing materials that then undergo fermentation and drying. In general, it is believed that short ripening time may lead to incomplete fermentation and thus to conditions (e.g. pH) that still allows growth or survival of enteric pathogens. Since these sausages are eaten raw and the infectious dose for STEC is very low, the producer must assure microbiologically safety. The products are believed to constitute a 'medium' risk hazard for STEC infection [39, 46, 47], and the US Food Safety and Inspection Service has developed guidelines [48] for sausage manufacturers to validate processes to ensure a 5 log10 unit (5D) reduction in counts of STEC O157:H7, for instance by heating the final product. Still, we believe that the consumers should be made aware of the inherent risk associated with these products [46].

We do not know why STEC survived the curing process in the incriminated "morrpølse". An evaluation committee suggested that there should be stricter requirement on hygienic quality for raw meat used for such products. In addition, the producer should document the effectiveness of the production process in reducing the level of pathogens if present in raw meat or other ingredients.


In summary, we report an outbreak of infections with a rare strain of STEC (O103:H25, stx 2-positive). More than half of the diagnosed patients developed HUS, indicating that the causative organism is particularly virulent. The source of the outbreak was cured sausages produced in one processing plant. The outbreak created a huge media attention, raised concerns about food safety and had large economical consequences for the producer. The potential for future outbreaks warrants a re-evaluation of the microbiologic health-hazards in the production of cured meat sausages.


  1. 1.

    Tarr PI, Gordon CA, Chandler WL: Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet. 2005, 365: 1073-1086.

    CAS  PubMed  Google Scholar 

  2. 2.

    Johnson KE, Thorpe CM, Sears CL: The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli. Clin Infect Dis. 2006, 43: 1587-1595. 10.1086/509573.

    Article  PubMed  Google Scholar 

  3. 3.

    Werber D, Behnke SC, Fruth A, Merle R, Menzler S, Glaser S, Kreienbrock L, Prager R, Tschape H, Roggentin P, Bockemuhl J, Ammon A: Shiga toxin-producing Escherichia coli infection in Germany: different risk factors for different age groups. Am J Epidemiol. 2007, 165: 425-434. 10.1093/aje/kwk023.

    Article  PubMed  Google Scholar 

  4. 4.

    Grahek-Ogden D, Lassen J, Nygard K: EHEC infections in Norway 1995-2004 [In Norwegian]. MSIS-rapport. 2005, 38-

    Google Scholar 

  5. 5.

    Lassen J, Heir E: Domestic outbreak of Enterohemorrhagic Escherichia coli (EHEC), summer 1999 [In Norwegian]. MSIS-rapport. 1999, 27-

    Google Scholar 

  6. 6.

    Lindstedt BA, Brandal LT, Aas L, Vardund T, Kapperud G: Study of polymorphic variable-number of tandem repeats loci in the ECOR collection and in a set of pathogenic Escherichia coli and Shigella isolates for use in a genotyping assay. J Microbiol Methods. 2007, 69: 197-205. 10.1016/j.mimet.2007.01.001.

    CAS  Article  PubMed  Google Scholar 

  7. 7.

    Brandal LT, Lindstedt BA, Aas L, Stavnes TL, Lassen J, Kapperud G: Octaplex PCR and fluorescence-based capillary electrophoresis for identification of human diarrheagenic Escherichia coli and Shigella spp. J Microbiol Methods. 2007, 68: 331-341. 10.1016/j.mimet.2006.09.013.

    CAS  Article  PubMed  Google Scholar 

  8. 8.

    Sekse C: Characterization of Escherichia coli O103:H25 Strains from HUS patients in Norway. In: Abstracts of the 6th International Symposium on Shiga Toxin (Verocytotoxin) Producing E coli Infections (VTEC 2006). 2006, Vancouver, Australia

    Google Scholar 

  9. 9.

    Persson S, Olsen KE, Ethelberg S, Scheutz F: Subtyping method for Escherichia coli shiga toxin (verocytotoxin) 2 variants and correlations to clinical manifestations. J Clin Microbiol. 2007, 45: 2020-2024. 10.1128/JCM.02591-06.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  10. 10.

    Nordic Committee on Food Analysis. 2008, []

  11. 11.

    Lindstedt BA: Multiple-locus variable number tandem repeats analysis for genetic fingerprinting of pathogenic bacteria. Electrophoresis. 2005, 26: 2567-2582. 10.1002/elps.200500096.

    CAS  Article  PubMed  Google Scholar 

  12. 12.

    Community outbreak of hemolytic uremic syndrome attributable to Escherichia coli O111:NM--South Australia 1995. MMWR Morb Mortal Wkly Rep. 1995, 44: 550-558.

  13. 13.

    Ammon A, Petersen LR, Karch H: A large outbreak of hemolytic uremic syndrome caused by an unusual sorbitol-fermenting strain of Escherichia coli O157:H-. J Infect Dis. 1999, 179: 1274-1277. 10.1086/314715.

    CAS  Article  PubMed  Google Scholar 

  14. 14.

    Institut. RK: Ein HUS-Ausbruch durch Sorbitol-fermentierende EHEC des Serovars O157:H– Untersuchungsergebnisse und Lehren für die Surveillance. Epidemiologisches Bulletin. 2003, 22: 171-175.

    Google Scholar 

  15. 15.

    Caprioli A, Luzzi I, Rosmini F, Resti C, Edefonti A, Perfumo F, Farina C, Goglio A, Gianviti A, Rizzoni G: Community-wide outbreak of hemolytic-uremic syndrome associated with non-O157 verocytotoxin-producing Escherichia coli. J Infect Dis. 1994, 169: 208-211.

    CAS  Article  PubMed  Google Scholar 

  16. 16.

    Tozzi AE, Niccolini A, Caprioli A, Luzzi I, Montini G, Zacchello G, Gianviti A, Principato F, Rizzoni G: A community outbreak of haemolytic-uraemic syndrome in children occurring in a large area of northern Italy over a period of several months. Epidemiol Infect. 1994, 113: 209-219.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  17. 17.

    Pollock KG, Young D, Beattie TJ, Todd WT: Clinical surveillance of thrombotic microangiopathies in Scotland, 2003-2005. Epidemiol Infect. 2008, 136 (1): 115-21. 10.1017/S0950268807008217.

    CAS  Article  PubMed  Google Scholar 

  18. 18.

    Beutin L, Kaulfuss S, Herold S, Oswald E, Schmidt H: Genetic analysis of enteropathogenic and enterohemorrhagic Escherichia coli serogroup O103 strains by molecular typing of virulence and housekeeping genes and pulsed-field gel electrophoresis. J Clin Microbiol. 2005, 43: 1552-1563. 10.1128/JCM.43.4.1552-1563.2005.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  19. 19.

    Mariani-Kurkdjian P, Denamur E, Milon A, Picard B, Cave H, Lambert-Zechovsky N, Loirat C, Goullet P, Sansonetti PJ, Elion J: Identification of a clone of Escherichia coli O103:H2 as a potential agent of hemolytic-uremic syndrome in France. J Clin Microbiol. 1993, 31: 296-301.

    CAS  PubMed  PubMed Central  Google Scholar 

  20. 20.

    Saito S, Yatsuyanagi J, Kinouchi Y, Sato H, Miyajima Y, Morita M: [A familial outbreak of verotoxin-producing Escherichia coli O103:H2 infection in which a calf was the suspected infectious source]. Kansenshogaku Zasshi. 1998, 72: 707-713.

    CAS  Article  PubMed  Google Scholar 

  21. 21.

    Gomez D, Miliwebsky E, Silva A, Deza N, Zotta C, Cotella O, Martinez EE, Chinen I, Fernandez PC, Rivas M: [Isolation of Shiga-toxin-producing Escherichia coli strains during a gastrointestinal outbreak at a day care center in Mar del Plata City]. Rev Argent Microbiol. 2005, 37: 176-183.

    CAS  PubMed  Google Scholar 

  22. 22.

    Rivas M, Miliwebsky E, Chinen I, Roldan CD, Balbi L, Garcia B, Fiorilli G, Sosa-Estani S, Kincaid J, Rangel J, Griffin PM: Characterization and epidemiologic subtyping of Shiga toxin-producing Escherichia coli strains isolated from hemolytic uremic syndrome and diarrhea cases in Argentina. Foodborne Pathog Dis. 2006, 3: 88-96. 10.1089/fpd.2006.3.88.

    CAS  Article  PubMed  Google Scholar 

  23. 23.

    Mackenzie AM, Lebel P, Orrbine E, Rowe PC, Hyde L, Chan F, Johnson W, McLaine PN: Sensitivities and specificities of premier E. coli O157 and premier EHEC enzyme immunoassays for diagnosis of infection with verotxin (Shiga-like toxin)-producing Escherichia coli. The SYNSORB Pk Study investigators. J Clin Microbiol. 1998, 36: 1608-1611.

    CAS  PubMed  PubMed Central  Google Scholar 

  24. 24.

    team. F: Outbreak of E. coli 0157:H7 infections associated with a brand of beefburgers in France. Euro Surveill. 2005, 10: E051103.1-

    Google Scholar 

  25. 25.

    Boerlin P, McEwen SA, Boerlin-Petzold F, Wilson JB, Johnson RP, Gyles CL: Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J Clin Microbiol. 1999, 37: 497-503.

    CAS  PubMed  PubMed Central  Google Scholar 

  26. 26.

    Gerber A, Karch H, Allerberger F, Verweyen HM, Zimmerhackl LB: Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study. J Infect Dis. 2002, 186: 493-500. 10.1086/341940.

    Article  PubMed  Google Scholar 

  27. 27.

    Werber D, Fruth A, Buchholz U, Prager R, Kramer MH, Ammon A, Tschape H: Strong association between shiga toxin-producing Escherichia coli O157 and virulence genes stx2 and eae as possible explanation for predominance of serogroup O157 in patients with haemolytic uraemic syndrome. Eur J Clin Microbiol Infect Dis. 2003, 22: 726-730. 10.1007/s10096-003-1025-0.

    CAS  Article  PubMed  Google Scholar 

  28. 28.

    Bielaszewska M, Kock R, Friedrich AW, von EC, Zimmerhackl LB, Karch H, Mellmann A: Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm?. PLoS ONE. 2007, 2: e1024-10.1371/journal.pone.0001024.

    Article  PubMed  PubMed Central  Google Scholar 

  29. 29.

    Bielaszewska M, Prager R, Kock R, Mellmann A, Zhang W, Tschape H, Tarr PI, Karch H: Shiga toxin gene loss and transfer in vitro and in vivo during enterohemorrhagic Escherichia coli O26 infection in humans. Appl Environ Microbiol. 2007, 73: 3144-3150. 10.1128/AEM.02937-06.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  30. 30.

    Friedrich AW, Zhang W, Bielaszewska M, Mellmann A, Kock R, Fruth A, Tschape H, Karch H: Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans. Clin Infect Dis. 2007, 45: 39-45. 10.1086/518573.

    CAS  Article  PubMed  Google Scholar 

  31. 31.

    Feng P, Dey M, Abe A, Takeda T: Isogenic strain of Escherichia coli O157:H7 that has lost both Shiga toxin 1 and 2 genes. Clin Diagn Lab Immunol. 2001, 8: 711-717. 10.1128/CDLI.8.4.711-717.2001.

    CAS  PubMed  PubMed Central  Google Scholar 

  32. 32.

    Karch H, Meyer T, Russmann H, Heesemann J: Frequent loss of Shiga-like toxin genes in clinical isolates of Escherichia coli upon subcultivation. Infect Immun. 1992, 60: 3464-3467.

    CAS  PubMed  PubMed Central  Google Scholar 

  33. 33.

    Ethelberg S, Olsen KE, Scheutz F, Jensen C, Schiellerup P, Enberg J, Petersen AM, Olesen B, Gerner-Smidt P, Molbak K: Virulence factors for hemolytic uremic syndrome, Denmark. Emerg Infect Dis. 2004, 10: 842-847.

    Article  PubMed  PubMed Central  Google Scholar 

  34. 34.

    Prager R, Liesegang A, Voigt W, Rabsch W, Fruth A, Tschape H: Clonal diversity of Shiga toxin-producing Escherichia coli O103:H2/H(-) in Germany. Infect Genet Evol. 2002, 1: 265-275. 10.1016/S1567-1348(02)00032-1.

    CAS  Article  PubMed  Google Scholar 

  35. 35.

    Urdahl AM, Beutin L, Skjerve E, Wasteson Y: Serotypes and virulence factors of Shiga toxin-producing Escherichia coli isolated from healthy Norwegian sheep. J Appl Microbiol. 2002, 93: 1026-1033. 10.1046/j.1365-2672.2002.01787.x.

    CAS  Article  PubMed  Google Scholar 

  36. 36.

    Urdahl AM, Cudjoe K, Wahl E, Heir E, Wasteson Y: Isolation of Shiga toxin-producing Escherichia coli O103 from sheep using automated immunomagnetic separation (AIMS) and AIMS-ELISA: sheep as the source of a clinical E. coli O103 case?. Lett Appl Microbiol. 2002, 35: 218-222. 10.1046/j.1472-765X.2002.01161.x.

    CAS  Article  PubMed  Google Scholar 

  37. 37.

    Espie E, Grimont F, Vaillant V, Montet MP, Carle I, Bavai C, de Valk H, Vernozy-Rozand C: O148 Shiga toxin-producing Escherichia coli outbreak: microbiological investigation as a useful complement to epidemiological investigation. Clin Microbiol Infect. 2006, 12: 992-998. 10.1111/j.1469-0691.2006.01468.x.

    CAS  Article  PubMed  Google Scholar 

  38. 38.

    Tilden J, Young W, McNamara AM, Custer C, Boesel B, Lambert-Fair MA, Majkowski J, Vugia D, Werner SB, Hollingsworth J, Morris JG: A new route of transmission for Escherichia coli: infection from dry fermented salami. Am J Public Health. 1996, 86: 1142-1145.

    Article  PubMed  PubMed Central  Google Scholar 

  39. 39.

    Naim F, Messier S, Saucier L, Piette G: A model study of Escherichia coli O157:H7 survival in fermented dry sausages--influence of inoculum preparation, inoculation procedure, and selected process parameters. J Food Prot. 2003, 66: 2267-2275.

    PubMed  Google Scholar 

  40. 40.

    Glass KA, Loeffelholz JM, Ford JP, Doyle MP: Fate of Escherichia coli O157:H7 as affected by pH or sodium chloride and in fermented, dry sausage. Appl Environ Microbiol. 1992, 58: 2513-2516.

    CAS  PubMed  PubMed Central  Google Scholar 

  41. 41.

    Faith NG, Parniere N, Larson T, Lorang TD, Kaspar CW, Luchansky JB: Viability of Escherichia coli O157:H7 in salami following conditioning of batter, fermentation and drying of sticks, and storage of slices. J Food Prot. 1998, 61: 377-382.

    CAS  PubMed  Google Scholar 

  42. 42.

    MacDonald DM, Fyfe M, Paccagnella A, Trinidad A, Louie K, Patrick D: Escherichia coli O157:H7 outbreak linked to salami, British Columbia, Canada, 1999. Epidemiol Infect. 2004, 132: 283-289. 10.1017/S0950268803001651.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  43. 43.

    From the Centers for Disease Control and Prevention. Escherichia coli O157:H7 outbreak linked to commercially distributed dry-cured salami--Washington and California, 1994. JAMA. 1995, 273: 985-986. 10.1001/jama.273.13.985.

  44. 44.

    Williams RC, Isaacs S, Decou ML, Richardson EA, Buffett MC, Slinger RW, Brodsky MH, Ciebin BW, Ellis A, Hockin J: Illness outbreak associated with Escherichia coli O157:H7 in Genoa salami. E. coli O157:H7 Working Group. CMAJ. 2000, 162: 1409-1413.

    CAS  PubMed  PubMed Central  Google Scholar 

  45. 45.

    Sartz L, De Jong B, Hjertqvist M, Plym-Forshell L, Alsterlund R, Lofdahl S, Osterman B, Stahl A, Eriksson E, Hansson HB, Karpman D: An outbreak of Escherichia coli O157:H7 infection in southern Sweden associated with consumption of fermented sausage; aspects of sausage production that increase the risk of contamination. Epidemiol Infect. 2008, 136 (3): 370-380. 10.1017/S0950268807008473.

    CAS  Article  PubMed  Google Scholar 

  46. 46.

    Sumner J, Ross T, Jenson I, Pointon A: A risk microbiological profile of the Australian red meat industry: risk ratings of hazard-product pairings. Int J Food Microbiol. 2005, 105: 221-232. 10.1016/j.ijfoodmicro.2005.03.016.

    Article  PubMed  Google Scholar 

  47. 47.

    Geraldine Duffy EC: A review of quantitative microbial risk assessment in the management of Escherichia coli O157:H7 on beef. Meat Science. 2007, 74: 76-88. 10.1016/j.meatsci.2006.04.011.

    Article  Google Scholar 

  48. 48.

    Reed C: Challenge study-Escherichia coli O157:H7 in fermented sausage. Letter to plant managers, 28 April 1995. U S Department of Agriculture, Food Safety and Inspection Service, Washington, D C. 1995

    Google Scholar 

Pre-publication history

  1. The pre-publication history for this paper can be accessed here:

Download references


We thank many individuals who participated in the outbreak investigation, all patients and their parents, health personnel in general practice and hospitals, the Norwegian Food Safety Authority, the Norwegian School of Veterinary Science, the National Veterinary Institute, and the municipal medical officers. We thank Dr. Alexander Friedrich at the Institute for Hygiene of the University Clinic in Münster, Germany, for carrying out the serologic tests, Dr. Flemming Scheutz at the Statens Serum Institute in Copenhagen, Denmark, for serotyping and characterization of the virulence marker profile in selected strains, and Dr. Dirk Werber at the Robert Koch Institute in Berlin for many valuable comments and advice.

Author information



Corresponding author

Correspondence to Karin Nygard.

Additional information

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

PA was responsible for leading the outbreak investigation. BS, KN and HME were principal investigators of the epidemiological investigation and BS drafted the manuscript. JL and GK were responsible for the microbiological investigation of the outbreak. BAL and LTB carried out the genotyping and virulence factor testing of patient and environmental isolates. All authors have read and approved the final manuscript.

Authors’ original submitted files for images

Below are the links to the authors’ original submitted files for images.

Authors’ original file for figure 1

Authors’ original file for figure 2

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Schimmer, B., Nygard, K., Eriksen, H. et al. Outbreak of haemolytic uraemic syndrome in Norway caused by stx 2-positive Escherichia coliO103:H25 traced to cured mutton sausages. BMC Infect Dis 8, 41 (2008).

Download citation


  • Haemolytic Uraemic Syndrome
  • Shiga Toxin
  • Outbreak Strain
  • Conditional Logistic Regression Model
  • Mince Meat